News
Everest Medicines (HKEX: 1952.HK) recently unveiled major breakthroughs in its proprietary AI-powered mRNA platform during its 2025 R&D Day held in Shanghai. The event showcased the company’s progress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback